SCHEMBL6974471

SCHEMBL6974471

CCCC[N]N(CC)C1CCCC1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.34
ADH1A P07327 3/20 0.34
ADH1C P00326 2/20 0.34
SIGMAR1 Q99720 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976009 0.98 CYP1A2 (0.38) CYP1A2ADH1AADH1CSIGMAR1
SCHEMBL6974283 0.92 ADH1C (0.33) ADH1AADH1C
SCHEMBL6963743 0.88 ADH1A (0.37) CYP1A2ADH1AADH1CSIGMAR1
SCHEMBL6975483 0.88 ADH1A (0.36) ADH1AADH1C
SCHEMBL6975732 0.86 ADH1A (0.39) CYP1A2ADH1AADH1CSIGMAR1
SCHEMBL6975147 0.80 ADH1A (0.37) CYP1A2ADH1AADH1CSIGMAR1
SCHEMBL6975102 0.79 ADH1C (0.37) ADH1AADH1C
SCHEMBL6971230 0.79 ADH1A (0.37) ADH1AADH1C
SCHEMBL6973231 0.79
SCHEMBL6974972 0.79 ADH1A (0.39) ADH1AADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0870765-B1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARM CO LTD (JP) 2003-11-19 EP disclosed
US-5981557-A HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-11-09 US disclosed
EP-0870765-A1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP disclosed